Anthem Biosciences eyes $397M public offering in India
India-based drug manufacturer Anthem Biosciences has its sights on going public with an IPO that could raise 34 billion rupees ($397 million).
Anthem filed its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
